Does BRODALUMAB Cause Upper respiratory tract infection? 6 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Upper respiratory tract infection have been filed in association with BRODALUMAB (Siliq). This represents 0.3% of all adverse event reports for BRODALUMAB.
6
Reports of Upper respiratory tract infection with BRODALUMAB
0.3%
of all BRODALUMAB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Upper respiratory tract infection From BRODALUMAB?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for BRODALUMAB.
What Other Side Effects Does BRODALUMAB Cause?
Psoriasis (418)
Drug ineffective (177)
Arthralgia (175)
Fatigue (152)
Psoriatic arthropathy (141)
Intentional product use issue (136)
Headache (126)
Therapy interrupted (126)
Product dose omission issue (124)
Disease recurrence (118)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which BRODALUMAB Alternatives Have Lower Upper respiratory tract infection Risk?
BRODALUMAB vs BROLUCIZUMAB
BRODALUMAB vs BROLUCIZUMAB-DBLL
BRODALUMAB vs BROMAZEPAM
BRODALUMAB vs BROMFENAC
BRODALUMAB vs BROMHEXINE